Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan 15;203(2):266-267.
doi: 10.1164/rccm.202008-3333LE.

Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details

Affiliations
Comment

Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details

Nicholas T Vozoris. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM, et al. Pharmacologic management of chronic obstructive pulmonary disease: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201:e56–e69. - PMC - PubMed
    1. Shohrati M, Ghanei M, Harandi AA, Foroghi S, Harandi AA. Effect of nebulized morphine on dyspnea of mustard gas-exposed patients: a double-blind randomized clinical trial study. Pulm Med. 2012;2012:610921. - PMC - PubMed
    1. Ekström M, Nilsson F, Abernethy AA, Currow DC. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease: a systematic review. Ann Am Thorac Soc. 2015;12:1079–1092. - PubMed
    1. Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev. 2016;3:CD011008. - PMC - PubMed
    1. Currow D, Louw S, McCloud P, Fazekas B, Plummer J, McDonald CF, et al. Australian National Palliative Care Clinical Studies Collaborative (PaCCSC) Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial. Thorax. 2020;75:50–56. - PubMed

MeSH terms

Substances